Literature DB >> 33680946

Development and Validation of a Personalized Survival Prediction Model for Uterine Adenosarcoma: A Population-Based Deep Learning Study.

Wenjie Qu1, Qingqing Liu1, Xinlin Jiao2, Teng Zhang2, Bingyu Wang1, Ningfeng Li1, Taotao Dong2, Baoxia Cui2.   

Abstract

BACKGROUND: The aim was to develop a personalized survival prediction deep learning model for adenosarcoma patients using the surveillance, epidemiology and end results (SEER) database.
METHODS: A total of 797 uterine adenosarcoma patients were enrolled in this study. Duplicated and useless variables were excluded, and 15 variables were selected for further analyses, including age, grade, positive lymph nodes or not, marital status, race, tumor extension, stage, and surgery or not. We created our deep survival learning (DSL) model to manipulate the data, which was randomly split into a training set (n = 519, 65%), validation set (n = 143, 18%) and testing set (n = 143, 18%). The Cox proportional hazard (CPH) model was also included comparatively. Finally, personalized survival curves were plotted for randomly selected patients.
RESULTS: The c-index for the CPH model was 0.726, and the Brier score was 0.17. For our deep survival learning model, we achieved a c-index of 0.774 and a Brier score of 0.14 in the external testing set. In addition, the limitations of the traditional staging system were revealed, and a personalized survival prediction system based on our risk scoring grouping was developed.
CONCLUSIONS: Our study developed a deep neural network model for adenosarcoma. The performance of this model was superior to that of the traditional Cox proportional hazard model. In addition, a personalized survival prediction system was developed based on our deep survival learning model, which provided more accurate prognostic information for adenosarcoma patients.
Copyright © 2021 Qu, Liu, Jiao, Zhang, Wang, Li, Dong and Cui.

Entities:  

Keywords:  adenosarcoma; artificial intelligence; database; deep learning; personalized model; survival prediction

Year:  2021        PMID: 33680946      PMCID: PMC7930479          DOI: 10.3389/fonc.2020.623818

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  32 in total

1.  Breast cancer data analysis for survivability studies and prediction.

Authors:  Nagesh Shukla; Markus Hagenbuchner; Khin Than Win; Jack Yang
Journal:  Comput Methods Programs Biomed       Date:  2017-12-12       Impact factor: 5.428

2.  Significance of lymph node metastasis on survival of women with uterine adenosarcoma.

Authors:  Hiroko Machida; Michael J Nathenson; Tsuyoshi Takiuchi; Crystal L Adams; Jocelyn Garcia-Sayre; Koji Matsuo
Journal:  Gynecol Oncol       Date:  2017-01-18       Impact factor: 5.482

Review 3.  Uterine Adenosarcoma.

Authors:  Uwe A Ulrich; Dominik Denschlag
Journal:  Oncol Res Treat       Date:  2018-10-17       Impact factor: 2.825

4.  Deep Learning-Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer.

Authors:  Kumardeep Chaudhary; Olivier B Poirion; Liangqun Lu; Lana X Garmire
Journal:  Clin Cancer Res       Date:  2017-10-05       Impact factor: 12.531

5.  Predicting Survival After Hepatocellular Carcinoma Resection Using Deep Learning on Histological Slides.

Authors:  Charlie Saillard; Benoit Schmauch; Oumeima Laifa; Matahi Moarii; Sylvain Toldo; Mikhail Zaslavskiy; Elodie Pronier; Alexis Laurent; Giuliana Amaddeo; Hélène Regnault; Daniele Sommacale; Marianne Ziol; Jean-Michel Pawlotsky; Sébastien Mulé; Alain Luciani; Gilles Wainrib; Thomas Clozel; Pierre Courtiol; Julien Calderaro
Journal:  Hepatology       Date:  2020-12       Impact factor: 17.425

Review 6.  Artificial intelligence in cancer imaging: Clinical challenges and applications.

Authors:  Wenya Linda Bi; Ahmed Hosny; Matthew B Schabath; Maryellen L Giger; Nicolai J Birkbak; Alireza Mehrtash; Tavis Allison; Omar Arnaout; Christopher Abbosh; Ian F Dunn; Raymond H Mak; Rulla M Tamimi; Clare M Tempany; Charles Swanton; Udo Hoffmann; Lawrence H Schwartz; Robert J Gillies; Raymond Y Huang; Hugo J W L Aerts
Journal:  CA Cancer J Clin       Date:  2019-02-05       Impact factor: 508.702

7.  Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases.

Authors:  Ye Zhang; Ying-Kai Hong; Dong-Wu Zhuang; Xue-Jun He; Ming-En Lin
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

8.  Development and validation of a novel prognostic model for long-term overall survival in liposarcoma patients: a population-based study.

Authors:  Shuai Cao; Jie Li; Kai Yang; Jun Zhang; Jiawei Xu; Chaoshuai Feng; Haopeng Li
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

9.  Novel prognostication of patients with spinal and pelvic chondrosarcoma using deep survival neural networks.

Authors:  Sung Mo Ryu; Sung Wook Seo; Sun-Ho Lee
Journal:  BMC Med Inform Decis Mak       Date:  2020-01-06       Impact factor: 2.796

View more
  1 in total

1.  Case Report: Uterine Adenosarcoma With Sarcomatous Overgrowth and Malignant Heterologous Elements.

Authors:  Yunuén I García-Mendoza; Mario Murguia-Perez; Aldo I Galván-Linares; Saulo Mendoza-Ramírez; Norma L García-Salinas; Julio G Moctezuma-Ramírez; Blanca O Murillo-Ortiz; Luis Jonathan Bueno-Rosario; Marco A Olvera-Olvera; Guillermo E Corredor-Alonso
Journal:  Front Med (Lausanne)       Date:  2022-01-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.